Platelet-derived TLT-1 promotes tumor progression by suppressing CD8+ T cells.
Tyagi T, Jain K, Yarovinsky TO, Chiorazzi M, Du J, Castro C, Griffin J, Korde A, Martin KA, Takyar SS, Flavell RA, Patel AA, Hwa J.
Tyagi T, et al. Among authors: yarovinsky to.
J Exp Med. 2023 Jan 2;220(1):e20212218. doi: 10.1084/jem.20212218. Epub 2022 Oct 28.
J Exp Med. 2023.
PMID: 36305874
Free PMC article.